FI20061156A0 - Uusia peptidejä - Google Patents
Uusia peptidejäInfo
- Publication number
- FI20061156A0 FI20061156A0 FI20061156A FI20061156A FI20061156A0 FI 20061156 A0 FI20061156 A0 FI 20061156A0 FI 20061156 A FI20061156 A FI 20061156A FI 20061156 A FI20061156 A FI 20061156A FI 20061156 A0 FI20061156 A0 FI 20061156A0
- Authority
- FI
- Finland
- Prior art keywords
- new peptides
- peptides
- new
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Nanotechnology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20061156A FI20061156A0 (fi) | 2006-12-27 | 2006-12-27 | Uusia peptidejä |
PCT/FI2007/000296 WO2008077993A1 (en) | 2006-12-27 | 2007-12-18 | Novel peptides |
US12/517,898 US8138151B2 (en) | 2006-12-27 | 2007-12-18 | Peptides |
CA002673248A CA2673248A1 (en) | 2006-12-27 | 2007-12-18 | Novel peptides |
EP07858320A EP2097439B1 (de) | 2006-12-27 | 2007-12-18 | Peptide |
JP2009543489A JP2010514741A (ja) | 2006-12-27 | 2007-12-18 | 新規ペプチド |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20061156A FI20061156A0 (fi) | 2006-12-27 | 2006-12-27 | Uusia peptidejä |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20061156A0 true FI20061156A0 (fi) | 2006-12-27 |
Family
ID=37623777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20061156A FI20061156A0 (fi) | 2006-12-27 | 2006-12-27 | Uusia peptidejä |
Country Status (6)
Country | Link |
---|---|
US (1) | US8138151B2 (de) |
EP (1) | EP2097439B1 (de) |
JP (1) | JP2010514741A (de) |
CA (1) | CA2673248A1 (de) |
FI (1) | FI20061156A0 (de) |
WO (1) | WO2008077993A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014073292A1 (ja) * | 2012-11-09 | 2014-05-15 | ジーンフロンティア株式会社 | 癌治療のための抗adam28抗体 |
CN114656523B (zh) * | 2022-03-14 | 2022-12-23 | 南京市第一医院 | 靶向siglec-10蛋白的多肽及免疫调控应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE184315T1 (de) | 1992-06-09 | 1999-09-15 | Biotie Therapies Oy | Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt |
PL360374A1 (en) | 2000-07-05 | 2004-09-06 | Biotie Therapies Corporation | Inhibitors of copper-containing amine oxidases |
FI20050574A0 (fi) | 2005-05-31 | 2005-05-31 | Faron Pharmaceuticals Oy | Koostumuksia, jotka kohdistuvat amiinioksidaaseihin in vivo |
-
2006
- 2006-12-27 FI FI20061156A patent/FI20061156A0/fi not_active Application Discontinuation
-
2007
- 2007-12-18 JP JP2009543489A patent/JP2010514741A/ja not_active Withdrawn
- 2007-12-18 CA CA002673248A patent/CA2673248A1/en not_active Abandoned
- 2007-12-18 WO PCT/FI2007/000296 patent/WO2008077993A1/en active Application Filing
- 2007-12-18 EP EP07858320A patent/EP2097439B1/de active Active
- 2007-12-18 US US12/517,898 patent/US8138151B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2097439B1 (de) | 2013-02-27 |
CA2673248A1 (en) | 2008-07-03 |
EP2097439A4 (de) | 2011-06-08 |
EP2097439A1 (de) | 2009-09-09 |
US8138151B2 (en) | 2012-03-20 |
JP2010514741A (ja) | 2010-05-06 |
WO2008077993A1 (en) | 2008-07-03 |
US20100316569A1 (en) | 2010-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2046826T3 (da) | Exendin-fusionsproteiner | |
DK3118221T3 (da) | Proteiner | |
BRPI0814587A2 (pt) | Peptídeos antibióticos | |
DE602006004717D1 (de) | Kapselperforationsmodul | |
DE602007002544D1 (de) | Nuancierungsmittel | |
BRPI0813942A2 (pt) | Polipeptídio ace2 | |
DE602007003893D1 (de) | Kippambossanordnung | |
DE602006020192D1 (de) | Riemenscheibenanorndung | |
DE602007000258D1 (de) | Kassetteneinspannmechanismus | |
AT504580A3 (de) | Scan-einrichtung | |
DE602007001280D1 (de) | Getränkeextraktor | |
DE602006019150D1 (de) | Riemenscheibenanorndung | |
DK2035451T3 (da) | Insulinoptrop peptidsyntese | |
BRPI0814971A2 (pt) | Proteína | |
ATE546437T1 (de) | Aminomethyl-4-imidazole | |
DE502007000218D1 (de) | nsetzungen | |
DE502007002453D1 (de) | Kunstoffverdichtergehäuse | |
DE602007000501D1 (de) | Breitbandrichtkoppler | |
DE602007004080D1 (de) | Tintenstrahlaufnehmer | |
DE502007001629D1 (de) | Rfahren | |
DE502007000361D1 (de) | Stanznieteinheit | |
DE602007000333D1 (de) | Napfbefestigungsvorrichtung | |
DE102006045567A8 (de) | Crimpstabilisierung | |
DE602007005649D1 (de) | Lastansteueranordnung | |
DE602007001098D1 (de) | Spindelmäheinheit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |